Answers are grounded in this paper and cite their sources.
Mini-review highlights the dual metabolic and growth-promoting roles of IGF-1 across disease states, indicating the necessity of evaluating its distinct impacts in clinical interventions.
Background: Insulin-like growth factor1 (IGF1) is a polypeptide that structurally is similar to human pro-insulin, one of the factors that is altered in obesity and many related diseases, hence a large body of research devoted to evaluate it. Methods: In this mini-review, we briefly explain the role of IGF1 in different conditions, including obesity, cardiovascular disease, and cancer through the results of review and original articles in both animal and human studies. Results: The short-term metabolic effect of IGF-1 is insulin-like, and its long-term effect is growth factor-like. IGF1 has different roles in the initiation and progression of different diseases, because in some cases, the anti-apoptotic effect, can help cell survival while in others, it may lead to cancer or increment of adipocytes. Conclusion: It is highly recommended to consider the different impacts of IGF1 in health and diseases prevention in future studies and interventions
No takes yet. Share an insight, caveat, or question.
AsghariHanjani et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: